BIOLIFE SOLUTIONS INC - 8-K Filing
BioLife Solutions agreed to merge with Repligen for $11.25 cash plus 0.1442 shares per share in a deal expected by Q4 2026. (Items: 1.01 Entry into a Material Definitive Agreement, 2.02 Results of Operations and Financial Condition, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $BLFS